Table 3.
Outcome | Overall (n = 74) | Hp1-1 (n = 11) | Hp2-1 (n = 39) | Hp2-2 (n = 24) | Hp1-1/2-1 (n = 50) | 95% CI* | P value* |
GOSE at discharge, mean ± SD | 3.1 ± 1.5 | 3.3 ± 1.3 | 3.4 ± 1.5 | 2.7 ± 1.5 | 3.4 ± 1.5 | −1.60–0.121 | 0.091 |
GOSE at 6 wk, mean ± SD | 3.9 ± 2.0 | 4.5 ± 1.9 | 3.9 ± 1.8 | 3.6 ± 2.2 | 4.1 ± 1.8 | −1.86–0.507 | 0.256 |
GOSE at 12 mo, mean ± SD | 5.2 ± 2.5 | 5.4 ± 2.7 | 5.5 ± 2.3 | 4.6 ± 2.8 | 5.5 ± 2.3 | −2.92–0.030 | 0.055 |
mRS at discharge, mean ± SD | 3.9 ± 1.3 | 4.1 ± 1.2 | 3.7 ± 1.3 | 4.0 ± 1.4 | 3.8 ± 1.3 | −0.141–1.25 | 0.114 |
mRS at 6 wk, mean ± SD | 3.1 ± 1.7 | 3.4 ± 1.8 | 2.8 ± 1.6 | 3.5 ± 1.8 | 2.9 ± 1.7 | −0.090–1.78 | 0.076 |
mRS at 12 mo, mean ± SD | 2.5 ± 2.0 | 2.5 ± 2.3 | 2.2 ± 1.7 | 2.9 ± 2.3 | 2.2 ± 1.9 | −0.006–2.38 | 0.051 |
Mortality, n (%) | 11 (14.9) | 1 (9.1) | 4 (10.3) | 6 (25.0) | 5 (10.0) | 0.871–13.3† | 0.079† |
For comparison between Hp2-2 and Hp1-1/2-1 controlling for age, GCS, WFNS, Fisher grade, Hunt–Hess grade, aneurysm size, and treatment type.
OR = 3.3, for comparison between Hp2-2 and Hp1-1/2-1 controlling for age.